| 000 | 01382 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517081228.0 | ||
| 264 | 0 | _c20161230 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1499-2752 | ||
| 024 | 7 |
_a10.3899/jrheum.141480 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRannio, Tuomas | |
| 245 | 0 | 0 |
_aEarly Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cApr 2016 |
||
| 300 |
_a699-706 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptides, Cyclic _ximmunology |
| 650 | 0 | 4 |
_aRemission Induction _xmethods |
| 650 | 0 | 4 |
_aRheumatoid Factor _xblood |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAsikainen, Juha | |
| 700 | 1 | _aKokko, Arto | |
| 700 | 1 | _aHannonen, Pekka | |
| 700 | 1 | _aSokka, Tuulikki | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 43 _gno. 4 _gp. 699-706 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3899/jrheum.141480 _zAvailable from publisher's website |
| 999 |
_c25735169 _d25735169 |
||